Early stages of Alzheimer's disease are alarming signs in injury deaths caused by traffic accidents in elderly people (≥60 years of age): A neuropathological study by Wijesinghe, P et al.
© 2018 Indian Journal of Psychiatry | Published by Wolters Kluwer - Medknow 471
ORIGINAL ARTICLE
Early stages of Alzheimer’s disease are alarming signs in injury deaths caused 
by traffic accidents in elderly people (≥60 years of age): A neuropathological 
study
Printha Wijesinghe, Catherine Gorrie1, S. K. Shankar2, Yasha T. Chickabasaviah2, Dhammika Amaratunga3, 
Sanjayah Hulathduwa4, K. Sunil Kumara5, Kamani Samarasinghe6, Yoo‑Hun Suh7, H. W. M. Steinbusch8, 
K. Ranil D. De Silva
Department of Anatomy, Faculty of Medical Sciences, Genetic Diagnostic Research Laboratory and Human Brain Bank 
Tissue Repository, University of Sri Jayewardenepura, Nugegoda, Sri Lanka, Departments of 4Forensic Medicine and 
6Pathology, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, 5Department of Judicial Medical 
Office, Colombo South Teaching Hospital, Colombo, Sri Lanka, 2Nonclinical Biostatistics, Janssen Research and Development 
(Retired), Raritan, USA, 1School of Medical and Molecular Biosciences, University of Technology Sydney, Sydney, 
Australia, 3Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, 
India, 7Department of Pharmacology, College of Medicine, Seoul National University, Seoul, South Korea, 8Department of 
Translational Neuroscience, Faculty Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
Address for correspondence: Prof. K. Ranil D. De Silva, 
Department of Anatomy, Faculty of Medical Sciences,  
Genetic Diagnostic and Research Laboratory and Human Brain 
Bank Tissue Repository, University of Sri Jayewardenepura, 
Nugegoda 10250, Sri Lanka.  
E‑mail: ranil@sjp.ac.lk
Background: There is little information available in the literature concerning the contribution of dementia in injury 
deaths in elderly people (≥60 years).
Aim: This study was intended to investigate the extent of dementia-related pathologies in the brains of elderly people 
who died in traffic accidents or by suicide and to compare our findings with age‑ and sex‑matched natural deaths in an 
elderly population.
Materials and Methods: Autopsy‑derived human brain samples from nine injury death victims (5 suicide and 4 traffic 
accidents) and nine age- and sex-matched natural death victims were screened for neurodegenerative and cerebrovascular 
pathologies using histopathological and immunohistochemical techniques. For the analysis, Statistical Package for the 
Social Sciences (SPSS) version 16.0 was used.
Results: There was a greater likelihood for Alzheimer’s disease (AD)-related changes in the elders who succumbed to 
traffic accidents (1 out of 4) compared to age‑ and sex‑matched suicides (0 out of 5) or natural deaths (0 out of 9) as 
assessed by the National Institute on Aging – Alzheimer’s Association guidelines. Actual burden of both neurofibrillary 
tangles (NFTs) and (SPs) was comparatively higher in the brains of traffic accidents, and the mean NFT counts were 
significantly higher in the region of entorhinal cortex (P < 0.05). However, associations obtained for other dementia-related 
pathologies were not statistically important.
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INTRODUCTION
Unnatural causes of death among elderly people on 
medicolegally examined autopsies have not been studied 
extensively. Accidents are the main causes of injury deaths 
among the elderly followed by suicide, whereas homicide 
is a rare or uncommon cause of injury death among these 
people.[1,2] To date, there have been no studies compared 
the extent of dementia-related pathologies in the brains of 
elderly people who died of injuries and natural diseases. 
There is a small number of studies from Western countries 
which investigated the extent of dementia-related 
pathologies in the brains of elderly victims of suicide[3-6] and 
fatal traffic accident brains.[7-9] Autopsy findings, however, 
were inconclusive. Primary objective of this study was 
to determine whether there is an over-representation 
of Alzheimer-related pathologies in the brains of 
elders (≥60 years)	who	succumbed	to	injury	deaths	caused	
by traffic accidents and suicide and to compare it with the 
brains	of	elders (≥60 years)	who	died	of	natural	diseases.
MATERIALS AND METHODS
Human brain samples were obtained at autopsy from 18 
elderly	subjects (≥60 years)	at	the	Department	of	Judicial	
Medical Office, Colombo South Teaching Hospital, following 
approval by the Institutional Scientific Ethics Committee to 
carry out the study and informed consent from kin. Among 
these	samples,	nine	brains	were	from	injury	deaths – five	
suicide	victims	and	four	fatal	traffic	accident	victims (mean	
age	 74.8  years  [7.3],	 mean	 age  [standard	 deviation];	
male:female  =  5:4)  –  and	 nine	 brains	 from	 natural	
deaths (mean	age	74.8 years [7.6];	male:female = 5:4).	
Brains of other injury deaths, including falls, drowning, 
war, adverse outcome of surgery, and homicide, were not 
obtained during this period. As this study was a retrospective 
study, an ante-mortem questionnaire was given to kin 
who were familiar with intellectual and motor functional 
status of the subjects before death. The purpose of this 
questionnaire was to obtain information on demographic 
data, medical history, family history, and health habits of the 
deceased. This information was held strictly confidential. All 
the recruited cases had incomplete clinical history, except 
one case which was clinically diagnosed as Parkinson’s 
disease  (PD).	 Specific	 neuroanatomical	 regions	 were	
sampled for paraffin embedding and sectioning from both 
hemispheres: hippocampus along with parahippocampal 
gyrus, superior frontal gyrus, middle temporal gyrus, 
superior parietal lobule, midbrain at superior colliculus 
level and deep white matters from corpus callosum-major 
inter-hemispheric white matter tract, and the circle of 
Willis (CW)	for	the	subsequent	atherosclerotic	study.
Following	 routine	 histological	 evaluation  (H  and  E),	
formalin-fixed paraffin-embedded brain sections were 
immunostained by standard immunoperoxidase technique 
following antigen retrieval by heat and DAB/H2O2 as 
the	 chromogen	 to	 visualize	 the	 immunolabeling  (DAKO	
Envision Detection System). For this screening, three 
antibodies, namely, (i) β‑amyloid  (Aβ)  –  monoclonal	
antibody (1:200 dilution) from Novacastra™, 
(ii)	ubiquitin – monoclonal	antibody (1:150	dilution)	from	
Novacastra™,	and	(iii)	phosphorylated	tau –	paired	helical	
filament	 (PHF)	 −1	 monoclonal	 antibody  (1:50	 dilution,	
A	 gift)	 were	 used.	 Phosphorylated	 tau‑  and	 Aβ-positive 
pathologies were graded semiquantitatively as given below.
1.	 Semi‑quantitative	 0–3	 scale  (0  ‑  none,	 +  ‑  low,	
++ ‑ moderate,	 and	+++ ‑ high)	 for	 tau‑positive	
neurons (neurons demonstrating tangle and pretangle 
pathology),	 neuritic	 plaques  (NPs),	 and	 neuropil	
threads (NTs)




The	 diagnostic	 criteria	 for	 Alzheimer’s	 disease  (AD)	
neuropathologic change was based on National Institute on 
Aging − Alzheimer’s	Association	guidelines (NIA‑AA)[10] – a	
practical approach which included:
•	 Consortium	 to	 Establish	 a	 Registry	 for	 AD  (CERAD)	
protocol for NP scoring[11]
•	 Braak	 and	 Braak	 staging	 scheme	 for	 neurofibrillary	
tangle  (NFT)	 degeneration[12,13] which was adapted to 
four	stages	that	improve	inter‑rater	reliability (stage	0,	
stage I or II, stage III or IV, and stage V or VI)[14]
•	 A	 modified	 version	 of	 Thal	 phases	 for	 Aβ plaque 
accumulation[15] which was adapted to four-point 
scale (phase	0,	phase	1	or	2,	phase	3,	and	phase	4	or	5).
AD neuropathologic change was ranked by three 
parameters: Aβ plaque phase, Braak and Braak NFT 
stage, and CEARD NP score to obtain ABC scores and 
then transformed into four levels: not, low, intermediate, 
or high.[10] Actual burden of AD-related pathologies 
(NFTs and SPs) were counted in specific brain regions such 
Conclusion: Our findings suggest that early Alzheimer stages may be a contributing factor to injury deaths caused by 
traffic accidents in elderly people whereas suicidal brain neuropathologies resembled natural deaths.
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as hippocampus, parahippocampus, superior frontal gyrus, 
and midbrain based on the methods described by Purohit 
et al.[16]	 For	 this	 purpose,	 a	 medium	 high	 power  (×20)	
objective lens producing a visual field of 0.785 mm2 (field	
diameter  =  2.0  mm)	 was	 used.	 Lesions	 were	 counted	
in	 medium	 high  (×200,	 Olympus	 U‑CTR30‑2	 Trinocular	
objective	tubes	and ×10	eye	piece)	power	fields	and	then	
converted	into	average	per ×200	as	follows:	for	superior	
frontal gyrus, areas with high NFTs/SPs were selected and 
visual counts were carried out in five nonoverlapping 
fields. For other regions, areas with high NFTs/SPs were 
identified in each subfield and then visual counts were 
carried	out	in	nonoverlapping	fields (wherever	possible	five	
nonoverlapping fields were selected).
Neuropathological	 criteria	 for	 Lewy	body	diseases  (LBDs)	
including	PD	and	dementia	with	Lewy	bodies (DLBs)	were	
based on NIA-AA[10] modifications to existing criteria 
which	 included	 Consortium	 on	 DLBs	 2005  (CDLB05)[17] 
and Braak PD staging[18] system. To detect Lewy bodies, 
α-synuclein immunohistochemistry is recommended 
as	 a	 preferred	method;	 however,	 in	 this	 study,	H  and E	
staining and ubiquitin immunohistochemistry which were 
recommended in CDLB 1996 criteria[19] were used. Cerebral 
amyloid	 angiopathy  (CAA)	 in	 leptomeningeal	 and	 cortical	
arteries of the specific neuroanatomical regions was 
graded based on Greenberg and Vonsattel[20] specifications 
and the average CAA grade was reported for each case. 
Intracranial	 atherosclerosis	 of	 the	 CW  (IASCW)	 was	
graded into four levels: none, mild, moderate, and severe 
based on the degree of stenosis of the CW component 
arteries[21]	 and	 the	 gross	 visual	 inspection  (macroscopic	
grading).[22] Extent of other cerebrovascular pathologies: 
microscopic	 infarcts	 in	 deep	white	matters  (7 µm thick) 
stained	 with	 Luxol	 fast	 blue  (LFB)	 and	 cresyl	 violet	 and	
white	 matter	 hyperintensities  (WMHs)	 in	 the	 neocortex	
and hippocampus regions stained with LFB and eosin 
were assessed semi-quantitatively as absent (none/rare) 
and	present  (above	 levels).	Due	 to	 the	high	 variability	of	
morphological findings and multifactorial pathogenesis of 
vascular	cognitive	impairment/vascular	dementia (VaD),[23-26] 
no generally accepted morphologic scheme for quantitating 
vascular brain injury and no validated neuropathological 
criteria for VaD have been established to date.[25,26] On the 
whole, the basis of VaD diagnosis is simply the presence 
of brain lesions related to vascular pathology and it highly 
depends on the neuropathologist’s judgment.
Statistical analysis
Results were analyzed using statistical software SPSS for 
windows version 16.0, SPSS Inc., Chicago, USA. Mann–
Whitney U-test was used to find the differences in AD-related 
neuropathological scores in different brain regions among 
injury deaths caused by traffic accidents and suicide and 
natural deaths.
RESULTS
This sample consisted of 18 deceased brains aged 
between	 60	 and	 87  years.	 The	 mean	 age	 between	
traffic	 accidents  (78.7  years  [3.1])	 and	 natural	
(78.5  years  [3.2])	 deaths;	 suicide  (71.6 years  [3.4])	 and	
natural	 deaths  (71.8  years  [3.2]);	 and	 traffic	 accidents	
(78.7 years [3.1])	and	suicide (71.6 years [3.4])	was	not	
significantly different (P >  0.05,	 Mann–Whitney	 U‑test).	
Sample summary on AD, LBD, and CAA neuropathological 
stages is given in Table  1.	 Among	 these	 samples,	 AD	
neuropathologic change for intermediate level considered 
as greater likelihood for dementia or cognitive impairment 
was found only in one out of four traffic accidents and for 
low level considered as inadequate evident was found in 
one out of four traffic accidents, one out of five suicides, 
and two out of nine natural deaths.
Figure 1	illustrates	the	percentage	of	cases	identified	with	
AD-related and cerebrovascular pathologies among injury 
and natural deaths. AD-related pathologies; Braak NFT stage, 
Thal Aβ phase, and CERAD NP score were comparatively 
Table 1: Sample summary on Alzheimer’s disease, cerebral amyloid angiopathy, and Lewy body disease 
neuropathological stages
Sample size Braak and Braak NFT 
stage
CERAD NP score Thal Aβ phase NIA‑AA 
(criteria)
CAA grade LBD stage
Traffic accidents 
(4 cases)
None 0% None 75.0% (3/4) None 50.0% (2/4) Not 75.0% (3/4) None 50.0% (2/4) None 100.0% (4/4)
Stage I-II 50.0% (2/4) Stage B 25.0% (1/4) Phase 1-2 50.0% (2/4) Low 25% (1/4) Grade 1 25%
stage III-IV 50.0% (2/4) Intermediate/
high 25.0% (1/4)
Grade 2 25%
Suicide (5 cases) None 0% None 80.0% (4/5) None 80.0% (4/5) Not 100.0% (5/5) None 80.0% (4/5) None 80.0% (4/5)
Stage I-II 60.0% (3/5) Stage B 20.0% (1/5) Phase 1-2 20.0% (1/5) Low 20% (1/5) Grade 1 20.0% (1/5) Brain stem-predominant- 
20.0% (1/5)
stage III-IV 40.0% (2/5)
Natural deaths 
(9 cases)
None 11.1% (1/9) None 100.0% (9/9) None 77.78% (7/9) Not 100.0% (9/9) None 88.89% (8/9) None 100.0% (9/9)
stage I-II 55.56% (5/9) Phase 1-2 22.2% (2/9) Low 22.2% (2/9) Grade 1 11.1% (1/9)
Stage III-IV 33.3% (3/9)
CAA – Cerebral amyloid angiopathy; LBD – Lewy body disease; CERAD NP – Consortium to establish a registry for Alzheimer’s disease protocol for neuritic 
plaque; Aβ – Amyloid; NIA‑AA – National Institute on Aging – Alzheimer’s association; NFT – Neurofibrillary tangles; NP – Neuritic plaques
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higher in traffic accidents compared to suicide or natural 
deaths. CAA and WMHs, which are most frequent coexisting 
cerebral small vessel diseases in the AD brains, were also 
identified prominently in the brains of traffic accidents. In 
contrast, large vessel pathologies; IASCW and white matter 
microscopic infarcts were identified prominently in natural 
deaths.
Association between cause of death and actual burden 
of	 AD‑related	 pathologies	 is	 presented	 in	 Table  2.	Mean	
counts of both NFTs and SPs were comparatively higher in 
the brains of traffic accidents compared to suicide or natural 
deaths. In particular, mean NFT counts were significantly 
higher (P < 0.05)	in	the	region	of	entorhinal	cortex.	Figure 2	
illustrates the hallmark lesions of AD including tau-positive 
NFTs and NPs, and Aβ-positive SPs observed in the brains of 
injury deaths. One among the 05 suicidal victims who had 
clinically diagnosed of PD presented brainstem-predominant 
Lewy bodies (stage 3) at neuropathological diagnosis.
DISCUSSION
Our study demonstrates a trend in elderly brain 
neuropathology where AD-related pathologies are 
predominant in injury deaths caused by traffic accidents, 
whereas large vessel pathologies; IASCW and microscopic 
infarcts are predominant in natural deaths and also in suicide. 
There is a significant overrepresentation of NFTs identified 
in the region of entorhinal cortex, the first area of the brain 
to be affected in AD.[27] Therefore, our results suggest that 
early AD-related neuropathological changes may contribute 
sufficiently to elderly injury deaths caused by traffic accidents 
by affecting their cognitive status. For this screening, we have 
used	the	recent	NIA‑AA	guidelines – a	practical	approach[10] to 
assess the neuropathological changes related to AD and LBDs. 
NIA-AA recommends immunohistochemistry as the most 
preferred methodology to screen AD-related pathologies 
and	it	was	followed	in	this	study (β-amyloid for Aβ plaques, 














































































































































































































































































































































Figure 1:  (a‑c)  Alzheimer  and  cerebrovascular  neuropathological  stages  among  injury  deaths  caused  by  traffic  accidents 
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phosphorylated tau/ubiquitin for CERAD NP score). Further, 
we have obtained the relative prevalence of comorbid 
pathologies including CAA, LBDs, IASCW, white matter 
microscopic infarcts, and WMHs between injury and natural 
deaths. Thus, apart from AD-related pathologies, other causes 
of dementia which remain as possible etiological factors in 
elderly person’s injury deaths could be reliably assessed. 
Moreover, we have employed a vigorous study method to 
count	NFTs	and	SPs	in	specific	brain	regions (hippocampus,	
entorhinal cortex, superior frontal gyrus, and midbrain); 
thus, true extent of AD-related pathologies was identified in 
respect of cause of death.
While this is the first autopsy verification study investigating 
dementia-related pathologies as etiological factors in injury 
deaths, we acknowledge that there are limitations such as 
sample size, incomplete clinical history of the recruited 
samples lacking objective psychometry and dementia scores, 
ubiquitin immunohistochemistry for labeling Lewy bodies 
instead of α-synuclein, semi-quantitative assessments of 
certain comorbid pathologies lacking exact quantifications, 
and nonavailability of some brain regions as specified under 
minimum tissue requirements by the NIA-AA guidelines. In 
addition to above restrains, our study was based on cases 
from suicide and fatal traffic accidents, whereas other 
causes of injury deaths such as falls and drowning which 
may result from cognitive impairments also need to be 
included in future concerns.
Suicide in elderly individuals presents unique challenges 
to clinicians because older people are less likely to report 
depressive symptoms.[28] While high rates of psychiatric 
symptoms during the course of illness have been 
reported,[29] the risk of suicide in people with dementia is 
generally considered to be low.[30,31] The contribution of 
dementia-related pathologies as the cause of suicide in 
a geriatric population remains questionable. Low risk of 
suicide in dementia cases has been partly attributed to the 
higher levels of personal supervision provided in such cases 
and the difficulties the person with cognitive impairments 
might have in planning and carrying out suicidal acts. 
Neuropathological confirmation of AD-related changes in 
elderly subjects who committed suicide has been limited 
to few case reports,[3,4] a single pilot case–control study,[5] 
and a large-scale study.[6] Rubio et al.[5] demonstrated 
that people with moderate-to-severe AD pathology were 
over-represented among those who committed suicide, 
suggesting that presence of Alzheimer pathology may 
increase the risk of suicide. However, a large scale study by 
Peisah et al.[6] demonstrated that Alzheimer pathology was 
not over-represented in elderly suicide victims. The above 
Figure 2: Hall mark lesions of AD. (a) Tau‑positive neurofibrillary 
tangles in hippocampal CA1 region at ×10 (scale bar 100 µm); (b) 
tau‑positive neuritic plaques  in hippocampal subiculum region 
at × 20 (scale bar 50 µm); (c) Aβ‑positive senile plaques in the 
region of middle temporal cortex at ×20 (scale bar 50 µm)
c
ba
Table 2: Actual burden of Alzheimer related pathologies among injury deaths caused by traffic accidents and suicide, 
and natural deaths
























Age - 78.75±3.12 78.50±3.17 0.883 71.60±3.41 71.80±3.25 0.916 78.75±3.12 71.60±3.41 0.221
Hippocampus NFTs 57.23±34.0 23.08±14.57 0.386 29.87±15.99 18.63±11.05 0.754 57.23±34.0 29.87±15.99 0.327
SPs 4.12±2.42 0.00±0.00 0.131 1.33±1.33 0.00±0.00 0.317 4.12±2.42 1.33±1.33 0.244
Entorhinal cortex NFTs 22.56±6.48 2.54±1.50 0.021* 6.11±3.75 20.65±9.31 0.754 22.56±6.48 6.11±3.75 0.050*
SPs 4.40±2.88 0.00±0.00 0.131 0.97±0.97 0.00±0.00 0.317 4.40±2.88 0.97±0.97 0.244
Superior frontal gyrus NFTs 0.60±0.45 0.06±0.06 0.321 0.15±0.10 0.00±0.00 0.136 0.60±0.45 0.15±0.10 0.500
SPs 2.69±2.21 0.00±0.00 0.131 1.94±1.94 0.20±0.20 0.881 2.69±2.21 1.94±1.94 0.561
Midbrain NFTs 5.12±2.22 3.33±2.28 0.386 1.01±0.51 4.84±1.95 0.116 5.12±2.22 1.01±0.51 0.140
SPs 0.13±0.13 0.00±0.00 0.317 0.00±0.00 0.00±0.00 1.000 0.13±0.13 0.00±0.00 0.264
All regions NFTs 85.51±36.90 29.02±15.92 0.248 37.15±14.51 44.12±16.40 0.917 85.51±36.90 37.15±14.51 0.142
SPs 11.34±6.59 0.00±0.00 0.131 4.23±4.23 0.20±0.20 0.881 11.34±6.59 4.23±4.23 0.383
Cortical and 
leptomenenigeal regions
CAA 2.25±1.31 0.00±0.00 0.131 0.60±0.60 1.20±0.80 0.521 2.25±1.31 0.60±0.60 0.244
P values are calculated using Mann‑Whitney U test and the significant levels are presented at *P<0.05. SE – Standard error; n – Number of cases; 
NFTs – Neurofibrillary tangles; SPs – Senile plaques; CAA – Cerebral amyloid angiopathy
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studies were limited by the availability of tissue sections, 
to hippocampal and neocortical examination. Thus, only 
prevalence of AD-related changes could be reliably assessed. 
In the absence of AD-related pathology, other causes of 
dementia such as LBDs or cerebrovascular diseases remain 
possible risk factors for the etiology in elderly persons’ 
suicidal behavior.
On the other hand, cognitive decline due to aging has 
received much attention as a possible risk factor for 
fatal traffic accidents in elderly populations. As dementia 
becomes a risk factor in traffic accidents, it is reasonable 
to expect increased dementia-related neuropathologies in 
the brains of accident victims. However, neuropathological 
confirmation of AD-related changes in such cases has also 
been limited with few numbers of studies. The study of 
Viitanen et al.[7] in the aged motor vehicle drivers highlighted 
that incipient AD may contribute to fatal crashes of aged 
drivers. Therefore, the forensic autopsy of these victims 
should include neuropathological examination. Another 
similar study done by Gorrie et al.[9] suggested that increased 
mild neutritic changes, even sparse NPs in the brains of 
older drivers may be a factor for their cognitive impairments 
and needs to be replicated elsewhere to clearly establish 
the association between early AD pathology and crash 
involvement. Gorrie et al.[8] also carried out a study in older 
pedestrians and suggested that AD-related pathologies, 
especially NFTs, are more frequent in fatally injured elders 
and suggested that cognitive impairment associated with 
AD; even the earliest stages of AD may be a risk factor for 
fatal traffic accidents in older pedestrians. In view of above 
studies, we found that none of the literature cumulatively 
reported the contribution of dementia, clinically and/or 
neuropathologically, to the injury deaths in elderly people. 
Further, none of the above studies assessed the actual 
burden/true extent of AD-related pathologies among fatal 
traffic accidents, suicide, and natural deaths. Therefore, 
despite small sample size, our study would yield a precise 
estimate of contribution of AD-related pathologies as an 
etiological factor in injury deaths caused by traffic accidents 
in elderly people.
There are limited numbers of studies on pathology of AD 
from	 India	 and	 other	 low‑  and	 middle‑income	 countries	
(LMICs)[16,32-42] where the proportion of people affected with 
dementia is anticipated to rise from 58% in 2010 to 63% in 
2030 and 71% in 2050.[43] Within South Asia, Sri Lanka shows 
the	fastest	aging;	13%	of	population	was	aged	over 60 years	
in	 2011	whereas	 it	 was ≤8%	 in	 rest	 of	 the	 South	 Asia.[44] 
Prevalence of dementia in Sri Lanka based on clinical diagnosis 
is higher by comparing similar studies of other South Asians 
reported	 so	 far;	 Sri	 Lanka  ‑ 3.98%,[45]	 India  ‑ 2.7%,[46] and 
Bangladesh ‑ 3.6%.[47] In Sri Lanka, injury deaths are the second 
major cause of mortality; 233/100,000 populations in 2008, 
whereas in other South Asian countries, it is comparatively 
low	 (Afghanistan  ‑149;	 Bangladesh  ‑  91;	 Bhutan  ‑  105;	
India ‑ 99;	Maldives ‑ 53;	Nepal ‑ 58;	Pakistan ‑ 92/100,000	
population in 2008).[44] Among the causes of injury deaths, 
suicide	 rate	 is	 in	 peak  (34.6	 per	 100,000	 population	 in	
2015) and comparatively higher than in other South 
Asian	populations (Nepal ‑ 7.2;	India ‑ 16.0;	Bhutan ‑ 12.1;	
Pakistan ‑ 2.5;	Bangladesh ‑ 6.0;	Maldives ‑ 11.0;	Afghanistan	
7.1 per 100,000 population).[48]	Road	traffic	deaths (road	traffic	
accidents [RTAs])	have	also	been	steadily	raising	in	Sri	Lanka	
and considered as the third leading cause of injury deaths 
after	suicide	and	collective	violence (war‑related	deaths)	and	
the annual death rate of RTAs is approximately 12.1/100,000 
population.[49] Although death counts due to RTAs are high 
between	the	ages	of	20	and	55 years,	which	is	likely	a	result	
of population age structure, the death rates continue to 
increase with age and are highest in elderly people.[49] These 
are serious public health issues in Sri Lanka as well as in other 
LMICs; however, it has not been received priority by the 
government healthcare sectors and it has not been studied 
extensively by the healthcare professionals. Taken together, 
our findings suggest that forensic autopsy should include 
neuropathological examination to the brains of elderly injury 
deaths	caused	by	fatal	accidents	aged ≥60 years.	Further,	it	
is important for primary carers and healthcare professionals 
to have an awareness of a possible link between cognitive 
impairment or early stages AD and cause of death in the 
elderly. This provides an opportunity to reduce the risk of 
injury deaths in this age group.
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